Skip to content
The Policy VaultThe Policy Vault

CombiganMedica

reduction of elevated intraocular pressure in patients with ocular hypertension

Preferred products

  • generic brimonidine 0.2%/timolol maleate 0.5% ophthalmic solution
  • generic dorzolamide 2%/timolol maleate 0.5% ophthalmic solution
  • generic dorzolamide 2%/timolol maleate 0.5% ophthalmic solution (generic Cosopt PF)

Initial criteria

  • Patient has tried one Step 1 Product (generic brimonidine 0.2%/timolol maleate 0.5% ophthalmic solution, generic dorzolamide 2%/timolol maleate 0.5% ophthalmic solution, or generic dorzolamide 2%/timolol maleate 0.5% ophthalmic solution [generic Cosopt PF])

Approval duration

1 year